BNY Mellon Innovators ETF (BKIV)
- CUSIP 09661T818
- NAV $ 32.52 As of 09/13/24
- CHG $ 0.32 (0.99 %)
- MKT PRICE $32.50 As of 09/13/24
- CHG $0.31 (0.96 %)
-
TOTAL EXPENSE RATIO
0.50%Net0.50%Gross
Why invest in this Fund?
- The fund seeks long-term capital growth by investing in equity securities of U.S. innovation-driven companies, across the market capitalization spectrum.
- The fund considers companies to be innovative that, through their intellectual property, provide leading edge products or services that are transformative or disruptive to existing business practices.
- Provides a growth-oriented investment for investors interested in leading edge companies with sustainable growth prospects.
- Liquid ETF structure allows investors to buy or sell any time the market is open.
(in millions)
Yields and Expense Ratio
30-DAY SEC YIELD as of 09/13/24 SUBSIDIZED |
UNSUBSIDIZED |
DIVIDEND YIELD (ANNUALIZED) as of 08/31/24 |
CONTRACTUAL FEE WAIVER END DATE |
PROSPECTUS FEE TABLE EXPENSE RATIO (%) as of 06/28/24 NET |
GROSS |
---|---|---|---|---|---|
-0.35 | -0.35 | 0.07 | - | 0.50 | 0.50 |
Yield fluctuates and past performance is no guarantee of future results.
The SEC 30-day Yield is calculated by dividing the net investment income per share earned during the period (calculated in accordance with regulatory guidelines) by the maximum offering price per share on the last day of the period.
Unsubsidized yield displays what the fund's 30-Day SEC Yield would have been had no fee waiver or expense reimbursement been in place during the period.
Gross Expenses is the total annual operating expense ratio for the fund, before any fee waivers or expense reimbursements. Net Expenses is the total annual operating expense ratio for the fund, after any applicable fee waivers or expense reimbursements. The Gross Expenses, or Net Expenses (if including fee waivers or expense reimbursements) is the actual fund expense ratio applicable to investors.
NAV - A fund's NAV is the sum of all its assets less any liabilities, divided by the number of shares outstanding.
Market Price - The market price is the most recent official closing price for the listed exchange.
Price/Earnings Ratio - Price-to-earnings (P/E) is the ratio of the market price of a firm’s common stock to its current (or predicted) earnings per share.
Price/Book Ratio - Price-to-book value (P/B) is a ratio used to compare a stock's market value with its book value. It is calculated by dividing the current closing price of the stock by the latest quarter’s book value (assets minus liabilities).
Weighted Avg Market Cap - Weighted average market cap is the average market capitalization of corporations in a fund or index, weighted by the percentage of the holding in the fund or index.
NAV - A fund's NAV is the sum of all its assets less any liabilities, divided by the number of shares outstanding.
Market Price - The market price is the most recent official closing price for the listed exchange.
Price/Earnings Ratio - Price-to-earnings (P/E) is the ratio of the market price of a firm’s common stock to its current (or predicted) earnings per share.
Price/Book Ratio - Price-to-book value (P/B) is a ratio used to compare a stock's market value with its book value. It is calculated by dividing the current closing price of the stock by the latest quarter’s book value (assets minus liabilities).
Weighted Avg Market Cap - Weighted average market cap is the average market capitalization of corporations in a fund or index, weighted by the percentage of the holding in the fund or index.
Portfolio Managers
-
John Porter
CIO, Head of Equity, Newton Investment Management North America, LLC
Managing Fund Since Inception
Joined Firm in 2016
Joined Industry in 1994
-
Edward R. Walter, CFA
Research Analyst, Newton Investment Management North America, LLC
Managing Fund Since Inception
Joined Firm in 1989
Joined Industry in 1989
Daily Statistics
As of 09/13/24 NAME |
30-DAY MEDIAN BID/ASK SPREAD |
PREVIOUS DAY VOLUME |
20-DAY AVG VOLUME |
PREMIUM/ DISCOUNT |
YTD Total Return (NAV) |
---|---|---|---|---|---|
BNY Mellon Innovators ETF
|
0.21% | 11 | 75 | -0.06% | 11.34% |
Past performance is no guarantee of future results.
30-Day Median Bid-Ask Spread - Gives investors the midpoint within the spread between an ETF’s selling price and buying price. It is calculated over the last 30 days in 10 second intervals by dividing the difference between the bid (sell price) and offer (buy price) by the midpoint of the National Best Bid Offer (NBBO) and identifying the median of those values.
20-Day Avg Volume - 20-Day Average Volume is the sum of last 20 days of trading volume divided by 20 days.
Premium / Discount - The amount the fund is trading above or below the reported NAV expressed as a percentage of the NAV. When the fund's market price is greater than the fund's NAV, it is said to be trading at a "Premium" and the percentage is expressed as a positive number. When the fund's market price is less than the fund's NAV, it is said to be trading at a "Discount" and the percentage is expressed as a negative number.
Total Returns
Month End
Average Annual As of 08/31/24 |
|||||||
---|---|---|---|---|---|---|---|
Name |
3 MO 08/31/24 |
YTD 08/31/24 |
1 YR | 3 YRS | 5 YRS | 10 YRS | Since Inception |
BNY Mellon Innovators ETF
BKIV |
3.29 | 11.87 | 20.93 | - | - | - | 23.08 |
Russell 3000 Growth Index
|
7.10 | 20.66 | 30.10 | 8.25 | 18.43 | 15.52 | - |
Russell 3000® Index
|
7.30 | 18.19 | 26.14 | 7.87 | 15.19 | 12.36 | - |
Quarter End
Average Annual As of 06/30/24 |
|||||||
---|---|---|---|---|---|---|---|
Name |
3 MO 06/30/24 |
YTD 06/30/24 |
1 YR | 3 YRS | 5 YRS | 10 YRS | Since Inception |
BNY Mellon Innovators ETF
BKIV |
4.75 | 13.82 | 20.46 | - | - | - | 28.97 |
Russell 3000 Growth Index
|
7.80 | 19.90 | 32.22 | 10.33 | 18.55 | 15.75 | - |
Russell 3000® Index
|
3.22 | 13.56 | 23.13 | 8.05 | 14.14 | 12.15 | - |
The performance data quoted represents past performance, which is no guarantee of future results. Share price, yield and investment return fluctuate and an investor's shares may be worth more or less than original cost upon redemption. Current performance may be lower or higher than the performance quoted. Returns less than 1 year are not annualized.
Market Price performance is calculated using the most recent NASDAQ Official Closing Price. Market Price returns do not represent investors’ returns had they traded shares at other times.
The Russell 3000® Growth Index measures the performance of the broad growth segment of the U.S. equity universe. It includes those Russell 3000 companies with relatively higher price-to-book ratios, higher forecasted growth rates and higher sales per share historical growth. The index is completely reconstituted annually to ensure new and growing equities are included and that the represented companies continue to reflect growth characteristics. An investor cannot invest directly in any index.
The Russell 3000® Index measures the performance of the largest 3,000 U.S. companies representing approximately 98% of the investable U.S. equity market. The Russell 3000® Index is constructed to provide a comprehensive, unbiased, and stable barometer of the broad market and is completely reconstituted annually to ensure new and growing equities are reflected. Investors cannot invest directly in any index.
The fund currently does not have a stated benchmark to measure performance against, however comparison of fund performance to an appropriate index indicates how the fund's returns compare with those of a broad measure of market performance. Past performance is no guarantee of future results.
Growth of $10,000 Investment
Historical NAV and Market Price
Historical Premium/Discount
Premium and Discount Summary Table
As of 09/13/24 | Calendar Year 2023 | Q1 2024 | Q2 2024 |
---|---|---|---|
Days Traded at Premium
|
145 | 38 | 35 |
Days Traded at Discount
|
15 | 22 | 28 |
Premium/Discount
Prospectus Fee Table Expense Ratios
Fees as stated in the prospectus Fee Description | Total Expense Ratio (%) |
---|---|
Management Fee | 0.50% |
Other Expenses | 0.00% |
Total Expenses | 0.50% |
Net Expenses | 0.50% |
The Total Expenses is the actual fund expense ratio applicable to investors.
Portfolio Manager/Sub-Investment Adviser
The fund's investment adviser is BNY Mellon ETF Investment Adviser, LLC (Adviser) and the fund's sub-adviser is Newton Investment Management North America LLC (NIMNA), an affiliate of the Adviser.
John Porter and Edward Walter are the fund's primary portfolio managers, positions they have held since the fund's inception in May 2023. Mr. Porter is Chief Investment Officer and Head of Equity at NIMNA. Mr. Walter is a portfolio manager and member of NIMNA's research team. Each portfolio manager is jointly and primarily responsible for the day-to-day management of the fund's portfolio.
Top Holdings
Holdings | % Portfolio Weight |
---|---|
NVIDIA CORP | 13.60 |
ALPHABET INC-CL C | 4.91 |
DREYFUS INSTITUTIONAL PRE | 4.34 |
INSMED INC | 4.30 |
COSTAR GROUP INC | 3.78 |
NETFLIX INC | 3.56 |
INSPIRE MEDICAL SYSTEMS I | 3.44 |
KLAVIYO INC-A | 2.88 |
REPLIGEN CORP | 2.79 |
FRESHPET INC | 2.63 |
ALIGN TECHNOLOGY INC | 2.55 |
SAREPTA THERAPEUTICS INC | 2.48 |
INTUITIVE SURGICAL INC | 2.39 |
CELSIUS HOLDINGS INC | 2.23 |
TRADE DESK INC/THE -CLASS | 2.13 |
MONDAY.COM LTD | 1.99 |
MONGODB INC | 1.98 |
CONFLUENT INC-CLASS A | 1.97 |
BLOCK INC | 1.91 |
DEXCOM INC | 1.90 |
TRANSMEDICS GROUP INC | 1.84 |
SHOPIFY INC - CLASS A | 1.79 |
NATERA INC | 1.73 |
CACTUS INC - A | 1.65 |
ASCENDIS PHARMA A/S - ADR | 1.63 |
LULULEMON ATHLETICA INC | 1.55 |
LIBERTY MEDIA CORP-LIB-NE | 1.53 |
DUTCH BROS INC-CLASS A | 1.50 |
ILLUMINA INC | 1.48 |
CYBERARK SOFTWARE LTD/ISR | 1.42 |
REDDIT INC-CL A | 1.42 |
CHEWY INC - CLASS A | 1.39 |
TWIST BIOSCIENCE CORP | 1.32 |
DRAFTKINGS INC-CL A | 1.24 |
AIRBNB INC-CLASS A | 1.23 |
DENALI THERAPEUTICS INC | 1.17 |
VITAL FARMS INC | 1.14 |
JPMORGAN CHASE & CO | 0.97 |
KEROS THERAPEUTICS INC | 0.93 |
GUARDANT HEALTH INC | 0.90 |
CRINETICS PHARMACEUTICALS | 0.86 |
PRIVIA HEALTH GROUP INC | 0.84 |
ELF BEAUTY INC | 0.75 |
PURE STORAGE INC - CLASS | 0.65 |
HUBSPOT INC | 0.61 |
PROCEPT BIOROBOTICS CORP | 0.59 |
XENON PHARMACEUTICALS INC | 0.52 |
GRAIL INC | 0.34 |
SECLEND | 0.00 |
Net Current Assets | -0.75 |
% Portfolio Weight is calculated using the closing market price of each security from the prior business day.
Asset Allocation
Main Risks
ETFs trade like stocks, are subject to investment risk, including possible loss of principal.
Equities are subject to market, market sector, market liquidity, issuer, and investment style risks, among other factors, to varying degrees. There can be no assurance that a company identified as an innovation-driven company by NIMNA will ultimately introduce a new product or service or that such product or service may not be significantly delayed or have the affect NIMNA anticipated. The returns on a portfolio of securities that are viewed by NIMNA as innovation-driven companies may trail the returns of a portfolio that is not limited to securities of innovation-driven companies. Investing only in securities of innovation-driven companies may affect the fund?s exposure to certain types of investments and may adversely impact the fund?s performance depending on whether such investments are in or out of favor in the market. The fund may significantly overweight or underweight certain companies, industries or market sectors, which may cause the fund's performance to be more or less sensitive to developments affecting those companies, industries or sectors.
The fund is non-diversified, which means that the fund may invest a relatively high percentage of its assets in a limited number of issuers. Therefore, the fund's performance may be more vulnerable to changes in the market value of a single issuer or group of issuers and more susceptible to risks associated with a single economic, political or regulatory occurrence than a diversified fund.
Although fund shares are listed for trading on an exchange and may be listed or traded on other U.S. and non-U.S. stock exchanges as well, there can be no assurance that an active trading market for such fund shares will develop or be maintained. Trading in fund shares may be halted due to market conditions or for reasons that, in the view of the listing exchange, make trading in fund shares inadvisable. In addition, trading in fund shares on an exchange is subject to trading halts caused by extraordinary market volatility pursuant to exchange "circuit breaker" rules. There can be no assurance that the requirements of the listing exchange necessary to maintain the listing of the fund will continue to be met or will remain unchanged or that fund shares will trade with any volume, or at all, on any stock exchange.
Please refer to the prospectus for a more complete discussion of the fund's main risks.
Dividend Schedule
Literature
PRODUCT INFORMATION
- Download
- Share
- Subscribe
- Order
BNY Mellon Thematic ETF Presentation | Download | Share | ||
BNY Mellon ETF Profile Sheet | Download | Share |
Prospectus and Reports
- Download
- Share
- Subscribe
- Order